Tag: Oramed Pharmaceuticals Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Lowered by ValuEngine

Added to Collection on: 2020-01-30 19:26:15

Tags for this article:

Life Sciences
Oramed
Price?earnings ratio
Biotechnology
Industry economics)
Specialty drugs
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Here is a bargain stock you should look at : Oramed Pharmaceuticals Inc. (ORMP)

Added to Collection on: 2020-11-30 13:30:00

Tags for this article:

Financial markets
Finance
Money
Stock market
Corporate finance
Stock
NASDAQ
Short
Initial public offering
IShares
Exchange-traded fund
Initial public offering of Facebook
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Analysts Expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) to Post -$0.16 EPS

Added to Collection on: 2020-11-26 00:45:00

Tags for this article:

IAC
Economy
Price?earnings ratio
ANGI Homeservices
Securities research
Angi
Pharmaceutical industry in China
Life Sciences
Finance
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Brokerages Expect Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) to Post -$0.16 Earnings Per ...

Added to Collection on: 2021-01-13 06:22:30

Tags for this article:

Life Sciences
Biotechnology
Health care
Price?earnings ratio
ANGI Homeservices
Pharmaceutical industry in China
Galena Biopharma
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Expected to Post Earnings of -$0.19 Per Share

Added to Collection on: 2021-02-26 06:00:00

Tags for this article:

Life Sciences
Economy
Biotechnology
Price?earnings ratio
ANGI Homeservices
Securities research
Specialty drugs
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace ...

Added to Collection on: 2021-03-23 15:33:45

Tags for this article:

Life Sciences
Biotechnology
Industry economics)
COVID-19 drug development
Casirivimab/imdevimab
NASDAQ
Gilead Sciences
BioCryst Pharmaceuticals
Regeneron Pharmaceuticals
Antisense therapy
Novo Nordisk
Protagonist Therapeutics Inc
Oramed Pharmaceuticals Inc.
Nuvation Bio Inc.
Radius Health Inc.
the Endocrine Society
Organogenesis Holdings Inc.
Bristol
Adagene Inc.
Sesen Bio Inc.
TreatmentChiasma, Inc.
Odonate Therapeutics Inc
Finch Therapeutics Group Inc.
Sierra Oncology Inc
MacroGenics Inc.
BioCryst Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc.
Acceleron Pharma Inc.
Harmony Biosciences Holdings Inc.
Reviva Pharmaceuticals Holdings Inc.
Seneca Biopharma Inc.
Aclaris Therapeutics Inc.
Theratechnologies Inc.
SI-BONE Inc.
Instil Bio Inc.
CTI BioPharma Corp

Click the tags to see associated articles and topics

View Article Details
How is the Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) performance outlook for the coming ...

Added to Collection on: 2021-03-23 18:00:07

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Economy of New York City
NASDAQ
Stock
Short
Initial public offering
Penny stock
Initial public offering of Facebook
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
At $10.2 Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) is Worth A Gamble

Added to Collection on: 2021-04-02 15:00:00

Tags for this article:

Financial markets
Finance
Money
Share trading
Stock market
Corporate finance
Stock
Day trading
NASDAQ
Short
Initial public offering
IShares
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Stock Jumped 6.03% Over A Month – Is There ...

Added to Collection on: 2021-07-03 15:22:30

Tags for this article:

Financial markets
Finance
Money
Stock market
Share trading
Economy of New York City
NASDAQ
Day trading
Stock
Initial public offering
Short
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Oramed Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Added to Collection on: 2024-07-22 00:53:45

Tags for this article:

Hepatitis
Steatohepatitis
Metabolic dysfunction–associated steatotic liver disease
Patent application
Fatty liver disease
Software patent
Oramed Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo